KNOW POLYMYXINS BETTER TO COMBAT ANTIMICROBIAL RESISTANCE: MICROBROTH DILUTION METHOD RECOMMENDED ROUTINE TESTING METHOD FOR SCREENING COLISTIN RESISTANCE IN GRAM NEGATIVE BACTERIA:
Main Article Content
Keywords
Colistin, Antimicrobial susceptibility testing (AST), Minimum Inhibitory Concentration (MIC), E- Strip test, Microbroth dilution (MBD), BD Phoenix M-50 Automated system, NCDC (National Centres for disease control)
Abstract
Introduction: With increasing threat of multidrug-resistant organisms (MDROs), Colistin has become popular in clinical practice. Minimum inhibitory concentrations (MICs) are used to monitor Colistin resistance. Microbroth dilution (MBD) stays as the reference testing method for determination of resistance to Colistin and is considered essential for patient management.
Aim: To evaluate performance of MBD over E-strip and automated systems for the determination of Colistin MIC.
Methodology: Study conducted in Microbiology Department of tertiary care hospital of western Uttar Pradesh from March-September 2024. Total of non-repeat clinically significant strains of common Gram-negative bacteria (GNBs) isolated from various clinical specimen of patients received from various departments of hospital for routine Culture Sensitivity testing were processed. MIC was obtained by E-strip, MBD and automated system was interpreted and compared as per NCDC guidelines.
Results: Total 232 GNBs isolated from various clinical specimens were studied for in-vitro Colistin susceptibility by E- Strip method, MBD and BD Phoenix M-50 automated system. Majority of isolates tested were of Escherichia coli 132(55%), followed by Pseudomonas aeruginosa 42(17.5%), Klebsiella spp. 32(13.33%), Acinetobacter baumannii complex 26 (10.83%). The overall Colistin resistance found in 45(18.75%) isolates by gold standard BMD method. Categorical agreement (CA), Essential agreement (EA), Very major error (VME) and Major error (ME) rates for Escherichia coli were 84.85%, 57.14%, 3.78%, and 2.27% by Automated system and 87.88%, 77.67%, 1.51%, 4.54% by E-strip.
Conclusion: Different susceptibility testing methods for Colistin show great variation in their results and BMD may be considered as best choice over E- strip and automated method.
References
2. Catry B, Cavaleri M, Baptiste K, Grave K, Grein K, Holm A et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents. 2015;46(3):297–306.
3. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: Old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother.1999;33:960-7.
4. Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30:557–96
5. Girlich D, Naas T, Dortet L. Comparison of the Superpolymyxin and Chrom ID Colistin R screening Media for the Detection of Colistin-resistant Enterobacteriaceae from spiked rectal swabs. Antimicrob Agents Chemother. 2019;63(1)
6. Matuschek E, Ahman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018; 24(8):865–70.
7. Sophia Vourli, Konstantina Dafopoulou, Georgia Vrioni, Athanassios Tsakris, Spyros Pournaras, Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2017; 72: 2528–2530.
8. Gupta P, Sharma R, Vyas A, Tak A. Comparative evaluation of broth microdilution with E-test, Vitek 2, and disk diffusion for susceptibility testing of colistin on Gram-negative bacteria. Indian J Med Sci 2021;73(1):93-8.
9. Arroyo LA, García-Curiel A, Pachón-Ibañez ME, Llanos AC, Ruiz M, Pachón J, Aznar J. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43(2):903-5.